208 related articles for article (PubMed ID: 21749320)
21. Nitric oxide inhibition causes an exaggerated pressor response in Yucatan miniature swine.
Vogl HW; Colletti AE; Zambraski EJ
Lab Anim Sci; 1997 Apr; 47(2):161-6. PubMed ID: 9150495
[TBL] [Abstract][Full Text] [Related]
22. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
Montanari A; Lazzeroni D; Pelà G; Crocamo A; Lytvyn Y; Musiari L; Cabassi A; Cherney DZI
Am J Physiol Renal Physiol; 2017 May; 312(5):F870-F878. PubMed ID: 28179255
[TBL] [Abstract][Full Text] [Related]
23. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB
Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
[TBL] [Abstract][Full Text] [Related]
24. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
25. Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade.
Bie P; Mølstrøm S; Wamberg S
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R428-35. PubMed ID: 19073902
[TBL] [Abstract][Full Text] [Related]
26. Volume expansion during acute angiotensin II receptor (AT(1)) blockade and NOS inhibition in conscious dogs.
Andersen JL; Sandgaard NC; Bie P
Am J Physiol Regul Integr Comp Physiol; 2002 Apr; 282(4):R1140-8. PubMed ID: 11893619
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of acute natriuresis in normal humans on low sodium diet.
Rasmussen MS; Simonsen JA; Sandgaard NC; Høilund-Carlsen PF; Bie P
J Physiol; 2003 Jan; 546(Pt 2):591-603. PubMed ID: 12527745
[TBL] [Abstract][Full Text] [Related]
28. Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.
Shahid M; Francis J; Matrougui K; Majid DS
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F217-24. PubMed ID: 20410217
[TBL] [Abstract][Full Text] [Related]
29. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
30. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
van der Linde NA; van den Meiracker AH; Boomsma F
J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
[TBL] [Abstract][Full Text] [Related]
31. Role of nNOS in regulation of renal function in angiotensin II-induced hypertension.
Cervenka L; Kramer HJ; Malý J; Heller J
Hypertension; 2001 Aug; 38(2):280-5. PubMed ID: 11509490
[TBL] [Abstract][Full Text] [Related]
32. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
Manning RD; Hu L; Reckelhoff JF
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
[TBL] [Abstract][Full Text] [Related]
34. Effects of oxytocin in normal man during low and high sodium diets.
Rasmussen MS; Simonsen JA; Sandgaard NC; Høilund-Carlsen PF; Bie P
Acta Physiol Scand; 2004 Jun; 181(2):247-57. PubMed ID: 15180798
[TBL] [Abstract][Full Text] [Related]
35. Renal function in mice: effects of volume expansion and angiotensin II.
Cervenka L; Mitchell KD; Navar LG
J Am Soc Nephrol; 1999 Dec; 10(12):2631-6. PubMed ID: 10589704
[TBL] [Abstract][Full Text] [Related]
36. Role of atrial natriuretic factor in impaired sodium excretion of normocapnic and hypercapnic patients with chronic obstructive lung disease.
Adnot S; Sediame S; Defouilloy C; Andrivet P; Viossat I; Brun-Buisson C; Chabrier PE; Laurent D
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1049-55. PubMed ID: 8214924
[TBL] [Abstract][Full Text] [Related]
37. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
Skov J; Dejgaard A; Frøkiær J; Holst JJ; Jonassen T; Rittig S; Christiansen JS
J Clin Endocrinol Metab; 2013 Apr; 98(4):E664-71. PubMed ID: 23463656
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide and renal effects of volume expansion in conscious monkeys.
Peterson TV; Carter AB; Miller RA
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1033-8. PubMed ID: 9139998
[TBL] [Abstract][Full Text] [Related]
40. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
Lahera V; Navarro J; Biondi ML; Ruilope LM; Romero JC
Am J Physiol; 1993 Feb; 264(2 Pt 2):F344-7. PubMed ID: 8383451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
